Figure 5.

Data from the ERA (Early Rheumatoid Arthritis) trial showing the superiority of etanercept over methotrexate, as determined by improvements in erosion and Sharp scores, but not joint-space narrowing score at 2 years. Adapted, with permission, from John Wiley & Sons, Inc. [15].

Yocum Arthritis Res Ther 2004 6(Suppl 2):S24-S30   doi:10.1186/ar997